These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 31638832)

  • 1.
    Higgins EM; Bos JM; Dotzler SM; John Kim CS; Ackerman MJ
    Circ Genom Precis Med; 2019 Nov; 12(11):e002648. PubMed ID: 31638832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidation of
    Higgins EM; Bos JM; Mason-Suares H; Tester DJ; Ackerman JP; MacRae CA; Sol-Church K; Gripp KW; Urrutia R; Ackerman MJ
    JCI Insight; 2017 Mar; 2(5):e91225. PubMed ID: 28289718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of a genetically-modified induced pluripotent stem cell line harboring a Noonan syndrome-associated gene variant MRAS p.G23V.
    Busley AV; Cyganek L
    Stem Cell Res; 2023 Jun; 69():103108. PubMed ID: 37141804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation-induced LZTR1 polymerization provokes cardiac pathology in recessive Noonan syndrome.
    Busley AV; Gutiérrez-Gutiérrez Ó; Hammer E; Koitka F; Mirzaiebadizi A; Steinegger M; Pape C; Böhmer L; Schroeder H; Kleinsorge M; Engler M; Cirstea IC; Gremer L; Willbold D; Altmüller J; Marbach F; Hasenfuss G; Zimmermann WH; Ahmadian MR; Wollnik B; Cyganek L
    Cell Rep; 2024 Jul; 43(7):114448. PubMed ID: 39003740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducible Pluripotent Stem Cell-Derived Cardiomyocytes Reveal Aberrant Extracellular Regulated Kinase 5 and Mitogen-Activated Protein Kinase Kinase 1/2 Signaling Concomitantly Promote Hypertrophic Cardiomyopathy in RAF1-Associated Noonan Syndrome.
    Jaffré F; Miller CL; Schänzer A; Evans T; Roberts AE; Hahn A; Kontaridis MI
    Circulation; 2019 Jul; 140(3):207-224. PubMed ID: 31163979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced Pluripotent Stem Cell-Derived Cardiomyocytes from a Patient with MYL2-R58Q-Mediated Apical Hypertrophic Cardiomyopathy Show Hypertrophy, Myofibrillar Disarray, and Calcium Perturbations.
    Zhou W; Bos JM; Ye D; Tester DJ; Hrstka S; Maleszewski JJ; Ommen SR; Nishimura RA; Schaff HV; Kim CS; Ackerman MJ
    J Cardiovasc Transl Res; 2019 Oct; 12(5):394-403. PubMed ID: 30796699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-Specific and Gene-Corrected Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Short QT Syndrome.
    Guo F; Sun Y; Wang X; Wang H; Wang J; Gong T; Chen X; Zhang P; Su L; Fu G; Su J; Yang S; Lai R; Jiang C; Liang P
    Circ Res; 2019 Jan; 124(1):66-78. PubMed ID: 30582453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome.
    Liang P; Sallam K; Wu H; Li Y; Itzhaki I; Garg P; Zhang Y; Vermglinchan V; Lan F; Gu M; Gong T; Zhuge Y; He C; Ebert AD; Sanchez-Freire V; Churko J; Hu S; Sharma A; Lam CK; Scheinman MM; Bers DM; Wu JC
    J Am Coll Cardiol; 2016 Nov; 68(19):2086-2096. PubMed ID: 27810048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe DCM phenotype of patient harboring RBM20 mutation S635A can be modeled by patient-specific induced pluripotent stem cell-derived cardiomyocytes.
    Streckfuss-Bömeke K; Tiburcy M; Fomin A; Luo X; Li W; Fischer C; Özcelik C; Perrot A; Sossalla S; Haas J; Vidal RO; Rebs S; Khadjeh S; Meder B; Bonn S; Linke WA; Zimmermann WH; Hasenfuss G; Guan K
    J Mol Cell Cardiol; 2017 Dec; 113():9-21. PubMed ID: 28941705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced myofilament calcium sensitivity aggravates abnormal calcium handling and diastolic dysfunction in patient-specific induced pluripotent stem cell-derived cardiomyocytes with MYH7 mutation.
    Guo G; Wang L; Li X; Fu W; Cao J; Zhang J; Liu Y; Liu M; Wang M; Zhao G; Zhao X; Zhou Y; Niu S; Liu G; Zhang Y; Dong J; Tao H; Zhao X
    Cell Calcium; 2024 Jan; 117():102822. PubMed ID: 38101154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.
    Ma N; Zhang JZ; Itzhaki I; Zhang SL; Chen H; Haddad F; Kitani T; Wilson KD; Tian L; Shrestha R; Wu H; Lam CK; Sayed N; Wu JC
    Circulation; 2018 Dec; 138(23):2666-2681. PubMed ID: 29914921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intronic CRISPR Repair in a Preclinical Model of Noonan Syndrome-Associated Cardiomyopathy.
    Hanses U; Kleinsorge M; Roos L; Yigit G; Li Y; Barbarics B; El-Battrawy I; Lan H; Tiburcy M; Hindmarsh R; Lenz C; Salinas G; Diecke S; Müller C; Adham I; Altmüller J; Nürnberg P; Paul T; Zimmermann WH; Hasenfuss G; Wollnik B; Cyganek L
    Circulation; 2020 Sep; 142(11):1059-1076. PubMed ID: 32623905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated Ca
    Malkovskiy AV; Ignatyeva N; Dai Y; Hasenfuss G; Rajadas J; Ebert A
    Biol Chem; 2020 Nov; 402(1):113-121. PubMed ID: 33544492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic Screening Using Patient-Derived Induced Pluripotent Stem Cells Identified Pyr3 as a Candidate Compound for the Treatment of Infantile Hypertrophic Cardiomyopathy.
    Sakai T; Naito AT; Kuramoto Y; Ito M; Okada K; Higo T; Nakagawa A; Shibamoto M; Yamaguchi T; Sumida T; Nomura S; Umezawa A; Miyagawa S; Sawa Y; Morita H; Lee JK; Shiojima I; Sakata Y; Komuro I
    Int Heart J; 2018 Sep; 59(5):1096-1105. PubMed ID: 30101858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the CACNA1C-R518C Missense Mutation in the Pathobiology of Long-QT Syndrome Using Human Induced Pluripotent Stem Cell Cardiomyocytes Shows Action Potential Prolongation and L-Type Calcium Channel Perturbation.
    Estes SI; Ye D; Zhou W; Dotzler SM; Tester DJ; Bos JM; Kim CSJ; Ackerman MJ
    Circ Genom Precis Med; 2019 Aug; 12(8):e002534. PubMed ID: 31430211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical, severe hypertrophic cardiomyopathy in a newborn presenting Noonan syndrome harboring a recurrent heterozygous MRAS variant.
    Pires LVL; Bordim RA; Maciel MBR; Tanaka ACS; Yamamoto GL; Honjo RS; Kim CA; Bertola DR
    Am J Med Genet A; 2021 Oct; 185(10):3099-3103. PubMed ID: 34080768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human-Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for
    Kondo T; Higo S; Shiba M; Kohama Y; Kameda S; Tabata T; Inoue H; Okuno S; Ogawa S; Nakamura S; Takeda M; Ito E; Li J; Liu L; Kuramoto Y; Lee JK; Takashima S; Miyagawa S; Sawa Y; Hikoso S; Sakata Y
    Circ Genom Precis Med; 2022 Oct; 15(5):e003522. PubMed ID: 35861968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. iPSC-Based Modeling of Variable Clinical Presentation in Hypertrophic Cardiomyopathy.
    Escribá R; Larrañaga-Moreira JM; Richaud-Patin Y; Pourchet L; Lazis I; Jiménez-Delgado S; Morillas-García A; Ortiz-Genga M; Ochoa JP; Carreras D; Pérez GJ; de la Pompa JL; Brugada R; Monserrat L; Barriales-Villa R; Raya A
    Circ Res; 2023 Jul; 133(2):108-119. PubMed ID: 37317833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noonan syndrome patient-specific induced cardiomyocyte model carrying SOS1 gene variant c.1654A>G.
    Gurusamy N; Rajasingh S; Sigamani V; Rajasingh R; Isai DG; Czirok A; Bittel D; Rajasingh J
    Exp Cell Res; 2021 Mar; 400(1):112508. PubMed ID: 33549576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activating MRAS mutations cause Noonan syndrome associated with hypertrophic cardiomyopathy.
    Motta M; Sagi-Dain L; Krumbach OHF; Hahn A; Peleg A; German A; Lissewski C; Coppola S; Pantaleoni F; Kocherscheid L; Altmüller F; Schanze D; Logeswaran T; Chahrokh-Zadeh S; Munzig A; Nakhaei-Rad S; Cavé H; Ahmadian MR; Tartaglia M; Zenker M
    Hum Mol Genet; 2020 Jul; 29(11):1772-1783. PubMed ID: 31108500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.